Immunity-and-matrix-regulatory Cells
Immunity-and-matrix-regulatory Cells Uses, Dosage, Side Effects, Food Interaction and all others data.
CAStem is composed of immunity- and matrix-regulatory cells (IMRCs), also known as M cells, which can be administered through injection. These IMRCs are differentiated from human embryonic stem cells that are expanded and then harvested. These cells are currently being investigated against lung injury and fibrosis -- conditions which are outcomes of lung disorders including COVID-19.IMRCs are similar to MSCs in terms of their capacity for self-renewal and tri-lineage differentiation. However, the difference comes with IMRCs displaying a higher quality of consistency, having stronger immunomodulatory and anti-fibrotic functions, and being stronger in potential treatment of lung injury and fibrosis.
| Trade Name | Immunity-and-matrix-regulatory Cells |
| Generic | Human Embryonic Stem Cell-derived M Cell |
| Human Embryonic Stem Cell-derived M Cell Other Names | CAStem, immunity- and matrix-regulatory cells, Immunity-and-matrix-regulatory cells, IMRCs, M cells |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Immunity-and-matrix-regulatory Cells works
IMRCs are different from cells such as the umbilical cord mesenchymal stem cells in gene expression profile; thus, this results in IMRCs possessing qualities such as higher expression levels of proliferative, immunomodulatory, and anti-fibrotic genes. Additionally, they have the ability to modulate immunity and regulate extracellular matrix production.
Innovators Monograph
You find simplified version here Immunity-and-matrix-regulatory Cells
